May 20, 2026 · Form 4 insider transaction
Weiner David B. bought 34,200 shares of Inovio Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 20, 2027.; This grant was made under the 2023 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy.